TM Capital Advises GMD PharmaSolutions in its Sale to McKesson

TM Capital is pleased to announce that we served as exclusive financial advisor to GMD PharmaSolutions (“GMD”), a portfolio company of Hammond, Kennedy, Whitney & Company, Inc. (“HKW”), in its sale to McKesson Corporation. GMD is a leading distributor of specialty pharmaceuticals focusing on the supply of ophthalmic drugs requiring cold chain expertise to clinics across Canada.

TM leveraged its deep knowledge in the healthcare services and pharmaceutical sectors to maximize value for GMD’s stakeholders and align the Company with a global strategic partner. The acquisition enables McKesson (NYSE:MCK) to expand its specialty pharmaceutical presence in Canada.

• Based in Oakville, Ontario, GMD offers turnkey solutions from initial importation to distribution / wholesale, pharma consulting, customized patient reimbursement programs, pharmacy dispensing and patient administration coordination
• GMD successfully pioneered innovative supply methods to improve efficiency in the point-of-care administration of high-value pharmaceuticals
• McKesson Corporation, with revenues of over $200 billion, is a global pharmaceutical distribution services and information technology company
• TM Capital’s relationship with HKW, a private equity firm founded in 1903 with offices in Indianapolis and New York, spans over 25 years